| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Gustave Roussy [Automatic translation follows] Prevention / Care / Research / Teaching, serving patients with #cancer. Gustave Roussy, the leading cancer center in Europe, 4th best cancer hospital in the world, constitutes a global center of expertise against cancer, serving patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Grand Paris). A private establishment of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and teaching Sectors: | 316 | 252 | 62 |
 | Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospital establishments. Founded in 1909 on a model designed by Marie Curie and still at the forefront, “from fundamental research to innovative care”, the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Cares The Institut Curie Hospital Complex is a reference center for breast cancers, eye tumors and pediatric cancers in particular. The research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians … Sectors: | 438 | 362 | 79 |
 | Retis [Automatic translation follows] RETIS is the French network of innovation professionals serving innovative companies and territories with the following missions: - The professionalization of members through the qualification of collaborators and the certification of organizations - Lobbying and network animation - Experimentation of pilot projects dedicated to innovative entrepreneurship at national and international level Complementary links in the same chain of networked innovation, the members of the RETIS network support the creation and development of innovative businesses in the regions on a daily basis with two missions and complementary professions - Support for these innovative companies - Animation of their … | 113 | 37 | 81 |
 | MoHo We are a global nation of changemakers launching the D-Day of Positive Impact. We are building a diverse and open nation of changemakers who are willing to address the biggest challenges of the XXIst century and invent a brighter future for all. We use three pillars for this mission: - The MoHo HQ: the first collider in Europe, located in the heart of Normandy in Caen - The MoHo D-Day Summit: each year, an intensive programme near the beaches of the D-Day to enable the acceleration of innovative projects with a high impact and the collision of ideas (first edition: … | 268 | 120 | 182 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 9417 | 7384 | 1144 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 575 | 339 | 356 |
 | Eurobiomed [Automatic translation follows] The key partner of future health leaders Eurobiomed is the competitiveness cluster for the health sector bringing together the Provence Alpes Côte d'Azur and Languedoc-Roussillon regions. Created on January 1, 2009, Le Pôle was recognized as a very efficient center following the audit carried out in 2012 by the state, the results are there in terms of number and amounts of projects financed, growth in turnover , export growth, direct jobs created and maintained by member companies. The Eurobiomed territory constitutes a large European health region. It is also ranked second nationally for the density of public … Sectors: | 245 | 130 | 136 |
 | CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: | 318 | 95 | 230 |
 | CNRS 80 years of building new worlds through knowledge The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, … Sectors: | 2210 | 1785 | 283 |
 | Région Hauts-de-France [Automatic translation follows] “For a sustainable and carbon-free economy with #rev3” Welcome to the official page of the Hauts-de-France Region. Our community is responsible for various missions serving its six million inhabitants: * Employment and economic development * High schools, higher education and research * Transportation * Planning and sustainable development of the territory, * Management of European funds * Sport, youth, culture, health, etc. Hauts-de-France is a plural region. #Leader in the #automotive industry, the railway industry, as in agriculture, our region is also the one which attracts the most foreign investors. The youngest region in France, Hauts-de-France is … Sectors: | 1395 | 1134 | 235 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 431 | 240 | 293 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: | 372 | 202 | 214 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: | 311 | 112 | 248 |
 | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: | 222 | 72 | 164 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: | 1592 | 1141 | 110 |
 | Réseau SATT [Automatic translation follows] Let's accelerate innovation The SATT Network is the association that brings together the 13 SATTs, Technology Transfer Acceleration Companies, whose mission is to simplify and professionalize the transfer of innovations from French academic research to businesses. Created in 2014, the association aims to carry out shared actions in order to increase the efficiency, readability and visibility of SATTs. Through its action, the SATT Network makes it possible to: - Provide a common portfolio of technologies to be transferred - Conclude partnerships - Show shared values - Carry out common communication With a unique maturation fund in France, … Tags: SATT Network | 97 | 31 | 52 |
 | MSD We aspire to be the premier research-intensive biopharmaceutical company. At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of … Sectors: | 1246 | 1063 | 114 |
 | Université Paris-Saclay [Automatic translation follows] 14 varied and complementary establishments are the Paris-Saclay University: 3 universities *, 4 grandes écoles ** and 7 research organizations ***. In total, we represent 48,000 students, 9,000 researchers and teacher-researchers, 4,600 doctoral students and 275 laboratories. 14 Various goal complementary institutions Make up University Paris-Saclay: 3 universities *, 4 Prestigious University-Level Colleges ** and 7 Research Organizations ***. WE represent 9,000 profits and researchers, 4,600 PhD Students, 275 Laboratories and 48,000 students. * University Paris-Sud, University Versailles St-Quentin-en-Yvelines and University of Evry. ** Graduate School Optical Institute, Agroparistech, CentralsUpelec, Normal School Paris-Saclay. *** CEA, CNRS, IHES, … Sectors: | 751 | 438 | 59 |
Health